Symbol="AGIO"
AssetType="Common Stock"
Name="Agios Pharm"
Description="Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts."
CIK="1439222"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="88 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1482896000"
EBITDA="-370639008"
PERatio="None"
PEGRatio="0"
BookValue="18.66"
DividendPerShare="0"
DividendYield="0"
EPS="-3.62"
RevenuePerShareTTM="0.346"
ProfitMargin="0"
OperatingMarginTTM="-19.9"
ReturnOnAssetsTTM="-0.19"
ReturnOnEquityTTM="-0.194"
RevenueTTM="19017000"
GrossProfitTTM="12536000"
DilutedEPSTTM="-3.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.74"
AnalystTargetPrice="39.8"
TrailingPE="-"
ForwardPE="2.466"
PriceToSalesRatioTTM="164.39"
PriceToBookRatio="1.623"
EVToRevenue="107.31"
EVToEBITDA="-2.763"
Beta="0.962"
num_52WeekHigh="34.76"
num_52WeekLow="19.43"
num_50DayMovingAverage="25.94"
num_200DayMovingAverage="26.69"
SharesOutstanding="55581000"
DividendDate="None"
ExDividendDate="None"
symbol="AGIO"
open="26.72"
high="27.30"
low="26.64"
price="26.81"
volume="670161.00"
latest_trading_day="2023-07-10"
previous_close="26.68"
change="0.13"
change_percent="0.4873%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="507762"
Change_recent_avg="-0.01"
Delta_recent_avg="0.99"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="-0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="487"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="689"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
